Methodological issues in clinical trials of opioids for chronic pain
Abstract
Clinical trials of opioid analgesics for chronic pain are recognized to frequently fail to distinguish the analgesic effect from placebo, despite known efficacy of the drug. This paper reviews the methodologic features of such trials that may be associated with risk of failure. A literature search yielded 23 randomized placebo-controlled studies of opioids with at least one week of continuous treatment; contacting pharmaceutical companies yielded six additional studies. A classification system and standard terminology were developed for describing the methodologic features of these trials. The methodologic features that appeared to augur well for success of the trials were slow titration of medications, flexible dosing, minimizing concomitant and rescue analgesics, homogeneous samples, particularly in terms of opioid use upon entry, fewer study sites (for the same sample size), and including as much data as possible in statistical analyses. Study designs that lead to high dropout rates lack internal validity, unless dropout is the intended endpoint of the trial. Opioid analgesics should be studied in a manner that is clincally relevant, and that supports internal validity. More systematic attention is needed to clinical research methodology.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Olson C, Neeper S. Why clinical trials fail. Surrey, UK: Brookwood Medical Publications, 1997.
2.
Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med 2003;17:576–587.
3.
Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesth Analg 2001;92:488–495.
4.
Sindrup SH, Madsen C, Brosen K, Jensen TS. The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels. Clin Pharmacol Ther 1999;66:636–641.
5.
Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd ed. New York: Springer-Verlag, 1998.
6.
DeMets DL. Statistical issues in interpreting clinical trials. J Intern Med 2004;255:529–537.
7.
Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Hoboken, NJ: John Wiley & Sons, 2002.
8.
Senn S. Cross-over trials in clinical research. West Sussex, UK: John Wiley Sons, 2002.
9.
Gossop M. The development of short opiate withdrawal scale (SOWS). Addict Behav 1990;14:487–490.
10.
Wesson DR, Ling W. The Clinical Opioid Withdrawal Scale (COWS). J Psychoactive Drugs 2003;35:253–259.
11.
Estfan B, LeGrand SB, Walsh D, Lagman RL, Davis MP. Opioid rotation in cancer patients: pros and cons. Oncology 2005;19:511–516.
12.
Faught E, Sachdeo RC, Remler MP, et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 1993;43:688–692.
13.
Sachdeo R, Beydoun A, Schachter S, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 2001;57:864–871.
14.
Quitkin FM, Rabkin JG. Methodological problems in studies of depressive didsorder: utility of the discontinuation design. J Clin Psychopharmacol 1981;1:283–288.
15.
Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533–538.
16.
Caldwell JR, Furst DE, Smith AL, et al. Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study. J Rheumatol 1998;25:30–35.
17.
Ciberre J, Kopec JA, Thome A, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 2004;51:738–745.
18.
Katz N, Ju WD, Krupa DA, et al., and the Vioxx Chronic Low Back Pain Study Group. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine 2003;28:851–859.
19.
Byas-Smith MG, Max MB, Muir J, Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design. Pain 1995;60:267–274.
20.
Leber PD, Davis CS. Threats to the validity of clinical trials employing enrichment strategies for sample selection. Control Clin Trials 1998;19:178–187.
21.
Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP. Age-dependent opioid escalation in chronic pain patients. Anesth Analg 2005;100:1740–1745.
22.
Bonica JJ. Management of pain. 2nd ed. Philadelphia: Lea & Febiger, 1990.
23.
Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998;23:2591–2600.
24.
Petrone D, Kamin M, Olson W. Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind randomized trial. J Clin Pharm Ther 1999;24:115–123.
25.
Vickers AJ. Statistical reanalysis of four recent randomized trials of acupuncture for pain using analysis of covariance. Clin J Pain 2004;20:319–323.
26.
Salsburg D. Why analysis of variance is inappropriate for multiclinic trials. Control Clin Trials 1999;20:453–68
27.
Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything—large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78:209–216.
28.
Vickers A. How to reduce the number of patients needed for randomized trials: a basic introduction. Complement Ther Med 2001;9:234–236.
29.
Jamison RN, Raymond SA, Levine JG, Slawsby EA, Nedeljkovic SS, Katz NP. Electronic diaries for monitoring chronic pain: 1-year validation study. Pain 2001;91:277–285.
30.
Molenberghs G, Thijs H, Jansen I, et al. Analyzing incomplete longitudinal clinical trial data. Biostatistics 2004;5:445–464.
31.
Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med 1999;130:995–1004.
32.
Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987–1991.
Information & Authors
Information
Published In
Copyright
© 2005.
Publication History
Published online: December 29, 2005
Published in print: December 29, 2005
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Opioid Trials: time for A New Approach? Enriched Enrollment Randomized Gradual Withdrawal Designs, Pain Management, 12, 3, (243-247), (2022).https://doi.org/10.2217/pmt-2021-0112
- Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence, Frontiers in Pain Research, 2, (2021).https://doi.org/10.3389/fpain.2021.721357
- Efficacy of a harvest graft substitute for recession coverage and soft tissue volume augmentation: A randomized controlled trial, Journal of Periodontology, 93, 3, (333-342), (2021).https://doi.org/10.1002/JPER.21-0131
- Comparison of the clinical outcomes between short-term and long-term opioid users with noncancer pain at pain clinics, Journal of Pharmacy And Bioallied Sciences, 12, 6, (728), (2020).https://doi.org/10.4103/jpbs.JPBS_284_19
- Rescue and concomitant analgesics in placebo-controlled trials of pharmacotherapy for neuropathic pain and low back pain, Pain, 161, 1, (3-10), (2019).https://doi.org/10.1097/j.pain.0000000000001690
- Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT, PAIN Reports, 4, 3, (e621), (2019).https://doi.org/10.1097/PR9.0000000000000621
- The Opioid Debate—PRO, The Clinical Journal of Pain, 35, 6, (468-472), (2019).https://doi.org/10.1097/AJP.0000000000000700
- Biosensor-based kinetic and thermodynamic characterization of opioids interaction with human μ-opioid receptor, European Journal of Pharmaceutical Sciences, 138, (105017), (2019).https://doi.org/10.1016/j.ejps.2019.105017
- Designing, Reporting, and Interpreting Clinical Research Studies About Treatments for Pain: Evidence-Based Medicine, Academic Pain Medicine, (23-26), (2019).https://doi.org/10.1007/978-3-030-18005-8_4
- Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial, The Journal of Pain, 19, 4, (382-394), (2018).https://doi.org/10.1016/j.jpain.2017.11.009
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.